Clinical Validation of the Unparalleled Sensitivity of the Novel ADPS Technology-Based EGFR Mutation Assay in Patients with Operable Non-Small Cell Lung Cancer.
Cancer research and treatment（2023）
Abstract
The highly sensitive and specific ADPS™ EGFR Mutation Test Kit would be useful in detecting the patients who have lung cancer with EGFR mutation, and can benefit from the EGFR targeted therapy.
MoreTranslated text
Key words
egfr mutation assay,technology-based,non-small
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined